May 2001
international
abstracts:
home
transplantation
|
|
|
| |
May 2001
international |
IN THIS
|
UPDATE ON THE CCCD
MILD COGNITIVE IMPAIRMENT
FAMILY INTERVENTIONS FOR CAREGIVERS
BEHAVIOUR THERAPY VS PHARMACOTHERAPY
EFFECT OF BEHAVIOURAL DISTURBANCES ON ADL
|
alzheimer's
issues: february 2003 november 2002 august 2002 may 2002 february 2002 november 2001 august 2001 may 2001 february 2001 november 2000 august 2000 june 2000 march 2000 november 1999 may 1999 february 1999 september 1998 june 1998 march 1998 december 1997 |
| EDITORIAL COMMENT |
UPDATE
ON THE CCCD |
|
Assessment of suspected dementia (CAN J NEUROL SCI 2001;28:SUPPL1 - S27-S41) |
|
H. CHERTKOW, H. BERGMAN, H.M. SCHIPPER, S. GAUTHIER, ET AL, MONTREAL, QC, JERUSALEM, ISRAEL |
To
view this abstract in
|
|
Screening for cognitive impairment and dementia in the elderly (CAN J NEUROL SCI 2001;28: SUPPL1 - S42-S51) |
|
CHRISTOPHER J.S. PATTERSON, DAVID A. GASS, HAMILTON, ON, HALIFAX, NS |
Sorry, this abstract is unavailable |
|
(CAN J NEUROL SCI 2001;228: SUPPL1 - S83-S95) |
|
LILIAN THORPE, BERNARD GROULX, SASKATOON, SK, MONTREAL, QC |
|
|
(CAN J NEUROL SCI 2001;28: SUPPL. 1 ð S96-S107) |
|
NATHAN HERRMANN, NORTH YORK, ON |
|
MILD COGNITIVE IMPAIRMENT |
|
| EDITORIAL COMMENT |
The group of patients with subjective and objective memory decline but
no dementia is attracting a lot of interest as an incipient stage of Alzheimer's
disease, possibly amenable to early therapy with agents such as tocopherol,
donepezil, rivastigmine, galantamine, old NSAIDs and new COX-2 selective
inhibitors. The natural history of what is now being called 'amnestic
MCI' is being reported from France (Ritchie et al ) and the U.S.
(Morris et al ). New consensus guidelines, such as the ones proposed
by Peterson et al, are needed to manage the increasing number of
persons consulting physicians for their MCI. |
|
Classification criteria for mild cognitive impairment:
(NEUROLOGY 2001;56:37-42) |
|
KAREN RITCHI, PHD, SYLVAINE ARTERO, MA, JACQUES TOUCHON, MD, MONTPELLIER, FRANCE |
|
|
(ARCH NEUROL 2001;58:397-405) |
|
JOHN C. MORRIS, MD, MARTHA STORANDT, PHD, J. PHILIP MILLER, DANIEL W. MCKEEL, MD, ET AL, ST. LOUIS, MO |
|
|
(NEUROLOGY 2001;56:1133-1142) |
|
R.C. PETERSEN, PHD, MD, J.C. STEVENS, MD, M. GANGULI, MD, MPH, E.G. TANGALOS, MD, ET AL, ROCHESTER, MN, PITTSBURGH, PA, LOS ANGELES, CA |
|
|
|
|
| EDITORIAL COMMENT |
Reducing caregiver
burden is increasingly recognized as being an essential component of management
for dementia. In this randomized controlled trial, Marriott et al use
a cognitive-behavioural intervention including carer education, stress management
and coping skills training to determine benefit for caregivers and patients.
Caregivers who received the intervention demonstrated significantly less
distress and depression than controls. More surprisingly, behavioural disturbances
in the dementia patients were also significantly reduced.  |
|
Effectiveness of cognitive-behavioural family intervention
in reducing (BR J PSYCHIATRY 2000;176:557-562) |
|
A. MARRIOTT, C. DONALDSON, N. TARRIER, A. BURNS, MANCHESTER, UK |
To
view this abstract in
|
BEHAVIOUR THERAPY VS PHARMACOTHERAPY |
|
| EDITORIAL COMMENT |
The relative strengths
and weaknesses of behavioural approaches vs pharmacotherapy for the treatment
of behavioural disturbances in dementia has long been debated, hampered
by a lack of head-to-head studies. In a randomized, placebo-controlled trial
comparing haloperidol, trazodone, behavioural management or placebo in behaviourally
disturbed outpatients, none of the active treatments were significantly
better than placebo. The debate continues... |
|
Treatment of agitation in AD: a randomized, placebo-controlled clinical trial (NEUROLOGY 2000;55:1271-1278) |
|
|
|
To
view this abstract in
|
EFFECT OF BEHAVIOURAL DISTURBANCES ON ADL |
|
| EDITORIAL COMMENT |
While it has usually been thought that cognitive dysfunction is the cause
of impaired activities of daily living (ADL), studies by Tekin et al
and Norton et al examined the effect of behavioural disturbances
on instrumental ADL. Results suggest that not only does behaviour have
significant effects on ADL, but that certain types of behaviours, such
as those related to frontal lobe systems, are particularly important. |
|
Activities of daily living in Alzheimer's
disease: (AM J GERIATR PSYCHIATRY 2001;9:81-86) |
|
SIBEL TEKIN, MD, LYNN A. FAIRBANKS, PHD, SUSAN O'CONNOR, RN, SUSAN ROSENBERG, RN, JEFFREY L. CUMMINGS, MD, LOS ANGELES, CA |
To
view this abstract in
|
|
(AM J GERIATR PSYCHIATRY 2001;9:41-48) |
|
LAUREN E. NORTON, PHD, PAUL F. MALLOY, PHD, STEPHEN SALLOWAY, MD, MS, BOSTON, MA |
|
|
|